Why Weight-Loss Drugs Are Suddenly Dominating Gulf Pharmacies

The line outside a local pharmacy in Dubai’s Marina neighborhood stretches nearly to the sidewalk café next door on a warm evening. Rows of tiny refrigerated boxes, the kind that pharmacists now watch over a bit more closely than they did a year ago, are reflected in the glass counter inside. They include weekly injections for weight loss, medications that, until recently, were only found in diabetes clinics. In many Gulf pharmacies, they are currently the most sought-after items.

It’s difficult to ignore how rapidly the conversation has evolved. A few years ago, weight-loss advice in the region centered on gym memberships and diet plans. Nowadays, drugs like tirzepatide and semaglutide, which were first created to regulate blood sugar, are frequently discussed. They evolved into something different at some point, a pharmaceutical shortcut that many people think could finally end the cycle of weight gain.

Even though it seems like it happened overnight, the change took time. Researchers have spent decades examining the hormones that control insulin and hunger. Eventually, they found that some substances could imitate the body’s gut signals, effectively informing the brain that it had consumed enough food. Surprisingly, patients started to consistently lose weight—sometimes more than 15% of their body mass.

Demand started to rise as word of those findings spread via private clinics and social media, first gradually and then suddenly.

Pharmacists now report something akin to a quiet gold rush across the Gulf. Patients visit pharmacies in Riyadh, Doha, and Abu Dhabi every week in the hopes that the next shipment has arrived due to frequent shortages. It appears that investors think the market will continue to expand. Several GCC nations continue to have some of the highest obesity rates in the world, and governments are becoming more concerned about the long-term costs of diabetes and cardiovascular disease.

In that way, these medications come at a strangely ideal time. The area has spent years creating parks, encouraging healthier lifestyles, and starting public health initiatives. However, the numbers hardly ever changed for the better. It turns out that dieting alone is more difficult than many policymakers had previously thought.

GLP-1 medications seem to slightly alter that equation. They help patients eat less without feeling hungry all the time by decreasing appetite and changing how the brain reacts to food. Physicians frequently talk about a psychological change: instead of constantly struggling with appetite, people now feel in control of it.

Nonetheless, there is a subtle skepticism among medical professionals. Yes, the weight loss is genuine, but the underlying biology is still uncooperative. The weight frequently returns when patients stop taking the medication. It appears that the body recalls its prior equilibrium and gradually moves in that direction.

These medications may end up being long-term therapies rather than short-term solutions, more akin to blood pressure medication than a dietary supplement.

The story is complicated by cost. Insurance coverage varies greatly throughout the Gulf, and a monthly course can cost hundreds of dollars. A more concerning trend has emerged as a result of this gap: compounded or counterfeit versions of the medications are being sold through online pharmacies and private clinics.

Although they originate from unregulated compounding facilities, some of these products make claims to contain tirzepatide or semaglutide. They frequently have unclear scientific foundations. The way a drug acts inside the body can be changed by different formulations, salt forms, or additives. Patients have occasionally reported unexpected side effects or dosage errors.

Regulators are starting to take notice. Health officials caution that injections that are fake or improperly compounded may actually be dangerous. However, enforcement is still inconsistent, particularly when social media marketing makes these goods seem nearly authentic.

Recently, while I was standing in a pharmacy in Doha, a pharmacist said something that perfectly encapsulated the moment. Customers arrive with screenshots on their phones — Instagram posts promising dramatic weight loss in a few months. Some people have optimism. Some are just inquisitive.

There is a feeling that medicine has evolved into both a cultural phenomenon and a form of treatment. And maybe that’s why the current boom is so complicated. Many patients actually benefit from these medications. Physicians observe improvements in blood sugar levels, weight loss, and occasionally the reversal of early-stage diabetes. At the same time, unsettling concerns about expectations are brought up by the unexpected popularity. Do people see the injections as a tool or as a substitute for changing their way of life?

The long-term picture is still up for debate among researchers. Similar treatments are being developed by more pharmaceutical companies, which could reduce costs and increase accessibility. In order to make them easier to use, some new formulations are even being tested as pills instead of injections.

For the time being, however, Gulf pharmacy shelves provide a clearer picture than any medical report. Small shipments of refrigerated boxes arrive. They swiftly vanish.

And the line silently reappears outside the pharmacy doors as people wait in the hopes that this little weekly injection will finally make a difference that diets by themselves rarely did.